Protective Host Immunity Against Pulmonary Cryptococcosis
宿主对肺隐球菌病的保护性免疫
基本信息
- 批准号:9214307
- 负责人:
- 金额:$ 40.85万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-03-01 至 2019-02-28
- 项目状态:已结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAntifungal AgentsCellsCessation of lifeClinicalCryptococcal MeningitisCryptococcus neoformansCryptococcus neoformans infectionDevelopmentEngineeringEpigenetic ProcessFundingHIV SeropositivityImmuneImmune responseImmunityImmunizationImmunizeImmunocompromised HostImmunologicsImmunotherapyIndividualIndustrial fungicideInfectionInflammatory ResponseInterferon-alphaInterventionLaboratoriesLeadLifeLiposomesLungMediatingMediator of activation proteinModelingMorbidity - disease rateMusMycosesNatural ImmunityPatientsPharmacologic SubstanceRoleSTAT1 geneSTAT1 proteinSignal TransductionT-LymphocyteTestingTimeTrainingVaccinesantimicrobialbasecombatdesignexpectationhistone modificationmacrophagemortalitynovelpathogenpreventprogramspublic health relevance
项目摘要
DESCRIPTION: Cryptococcus neoformans infections are a significant cause of morbidity and mortality among AIDS patients. Global estimates suggest that one million cases of cryptococcal meningitis occur each year resulting in over 625,000 deaths. Because host immune responses are so vital to the control of cryptococcosis, the overall objective of our laboratory is to determine the mechanism(s) necessary to elicit protective immunity against C. neoformans infections. To this end, the studies conducted during the previous funding period employed a C. neoformans strain engineered to express interferon (IFN)-γ, designated H99γ, to define protective immune responses against C. neoformans in mice. Importantly, we established for the first time that protective immunity against pulmonary cryptococcosis can be generated in T cell deficient hosts, thus providing "proof of concept" that vaccines targeting C. neoformans can elicit protection against cryptococcosis in immunocompromised patients. Additionally, preliminary results included herein show that signal transducer and activator of transcription 1 (STAT)-mediated classical macrophage (MΦ) activation is essential for the development of protective immunity against pulmonary cryptococcosis. Moreover, MΦs isolated from protectively immunized mice several weeks post-immunization have enhanced pro-inflammatory responses against C. neoformans that are associated with changes in their epigenetic programming. These exciting results support a novel paradigm for "trained" innate immunity against fungal pathogens. Altogether, our studies lead us to hypothesize that STAT1 signaling in MΦs is essential for classical MΦ activation and the induction of vaccine-mediated immunity against pulmonary C. neoformans infection. We plan to test our hypothesis and accomplish our overall objective by pursuing the following Specific Aims: (1) define the role of STAT1 signaling in the initiation of classical MΦ activation and antimicrobial activity against C. neoformans, (2 determine the mechanism(s) that facilitates STAT1-mediated classical MΦ activation and protection following immunization with C. neoformans strain H99γ, and (3) identify the epigenetic changes within MΦs of protectively immunized mice that are associated with protective immunity against C. neoformans.
描述:艾滋病患者中的加密型新甲壳虫感染是发病率和死亡率的重要原因。全球估计表明,每年有100万例隐球菌脑膜炎病例导致62.5万人死亡。由于宿主免疫调查对于控制隐孢子球的控制至关重要,因此我们实验室的总体目标是确定引起针对Neoformans C. Neoformans感染的保护免疫学所必需的机制。为此,在上一个资金期间进行的研究采用了为表达干扰素(IFN)-γ(指定为H99γ)设计的C. neoformans菌株,以定义小鼠中针对Neoformans的受保护的免疫复杂。重要的是,我们首次确定可以在缺乏T细胞的宿主中生成保护免疫组织性侵害肺隐球菌的免疫组织性,因此提供了“概念证明”,以使靶向Neoformans的疫苗可以在不受影响的患者的患者中引起靶向Neoformans的疫苗。此外,本文包括的初步结果表明,转录1(STAT)介导的经典巨噬细胞(Mφ)激活的信号换能器和激活因素对于开发受保护的免疫组织化学显微关节crompococococococococococococococococococococococococococococococococococococococococococococococococococococococococococococococococococococococococococococococococosis至关重要。此外,免疫后数周从受保护的免疫小鼠中分离出来的MφS增强了与新生梭菌的促炎反应,这与其表观遗传编程的变化有关。这些令人兴奋的结果支持了针对真菌病原体的“训练”先天免疫学的新型范式。总的来说,我们的研究使我们假设MφS中的STAT1信号对于经典的Mφ激活和诱导疫苗介导的免疫学对肺C. Neoformans感染至关重要。我们计划通过追求以下特定目的来检验我们的假设并实现我们的总体目标:(1)定义STAT1信号在启动经典Mφ激活和针对Neoformans的抗菌活性中的作用(2确定促进STAT1介导的经典Mφ激活和保护性的机制,并识别C. neoformants c. neoforments(3)在受保护的免疫对抗梭状芽胞杆菌的免疫相关的受保护的免疫小鼠的Mφ中。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Floyd L. Wormley其他文献
Floyd L. Wormley的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Floyd L. Wormley', 18)}}的其他基金
5-Lipoxygenase Inhibition as a Therapy to Prevent Cryptococcus-related IRIS
5-脂氧合酶抑制作为预防隐球菌相关 IRIS 的疗法
- 批准号:
10358634 - 财政年份:2021
- 资助金额:
$ 40.85万 - 项目类别:
5-Lipoxygenase Inhibition as a Therapy to Prevent Cryptococcus-related IRIS
5-脂氧合酶抑制作为预防隐球菌相关 IRIS 的疗法
- 批准号:
10256128 - 财政年份:2021
- 资助金额:
$ 40.85万 - 项目类别:
Induction of Protection Against Cryptococcus neoformans in Immune Deficient Hosts
在免疫缺陷宿主中诱导针对新型隐球菌的保护
- 批准号:
8499245 - 财政年份:2012
- 资助金额:
$ 40.85万 - 项目类别:
Induction of Protection Against Cryptococcus neoformans in Immune Deficient Hosts
在免疫缺陷宿主中诱导针对新型隐球菌的保护
- 批准号:
8414616 - 财政年份:2012
- 资助金额:
$ 40.85万 - 项目类别:
Identification of C. neoformans proteins that induce protective immunity.
诱导保护性免疫的新型隐球菌蛋白的鉴定。
- 批准号:
7990317 - 财政年份:2010
- 资助金额:
$ 40.85万 - 项目类别:
Identification of C. neoformans proteins that induce protective immunity.
诱导保护性免疫的新型隐球菌蛋白的鉴定。
- 批准号:
8067135 - 财政年份:2010
- 资助金额:
$ 40.85万 - 项目类别:
Protective Host Immunity Against Pulmonary Cryptoccoccosis
宿主对肺隐球菌病的保护性免疫
- 批准号:
7775100 - 财政年份:2007
- 资助金额:
$ 40.85万 - 项目类别:
Protective Host Immunity Against Pulmonary Cryptoccoccosis
宿主对肺隐球菌病的保护性免疫
- 批准号:
8019452 - 财政年份:2007
- 资助金额:
$ 40.85万 - 项目类别:
Protective Host Immunity Against Pulmonary Cryptoccoccosis
宿主对肺隐球菌病的保护性免疫
- 批准号:
7587322 - 财政年份:2007
- 资助金额:
$ 40.85万 - 项目类别:
Protective Host Immunity Against Pulmonary Cryptoccoccosis
宿主对肺隐球菌病的保护性免疫
- 批准号:
7365221 - 财政年份:2007
- 资助金额:
$ 40.85万 - 项目类别:
相似国自然基金
典型唑类抗真菌剂在斑马鱼中的富集代谢规律及其性腺激素干扰效应研究
- 批准号:21507163
- 批准年份:2015
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
群体感应系统阻遏抗真菌剂藤黄绿菌素生物合成的分子机制
- 批准号:31270083
- 批准年份:2012
- 资助金额:82.0 万元
- 项目类别:面上项目
抗真菌剂藤黄绿菌素生物合成自诱导的分子机理研究
- 批准号:30800009
- 批准年份:2008
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Develop and Assess mRNA Lipid Nanoparticle Vaccines Against Cryptococcosis
开发并评估针对隐球菌病的 mRNA 脂质纳米颗粒疫苗
- 批准号:
10616313 - 财政年份:2023
- 资助金额:
$ 40.85万 - 项目类别:
Translational Regulation of Candida glabrata Azole Resistance
光滑念珠菌唑耐药性的转化调控
- 批准号:
10681915 - 财政年份:2023
- 资助金额:
$ 40.85万 - 项目类别:
Define the molecular bases for cryptococcal adaptation to host conditions by the RAM pathway
通过 RAM 途径定义隐球菌适应宿主条件的分子基础
- 批准号:
10627371 - 财政年份:2023
- 资助金额:
$ 40.85万 - 项目类别:
Coordinated responses to host-derived stresses in C. neoformans
新型隐球菌对宿主应激的协调反应
- 批准号:
10637411 - 财政年份:2023
- 资助金额:
$ 40.85万 - 项目类别:
The biology of Cryptococcus neoformans melanization
新型隐球菌黑化的生物学
- 批准号:
10660435 - 财政年份:2023
- 资助金额:
$ 40.85万 - 项目类别: